NEW MJ NEWS

AbbVie to Host Third-Quarter 2023 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its third-quarter 2023 financial results on Friday, October 27, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2023-earnings-conference-call-301942331.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$EDXC Planning Revolutionary Standard Compliant Smart Glasses for the Cannabis Industry

Endexx to Develop Smart Glasses Based Compliance Solutions for the Cannabis Industry…

American Cannabis Company, Inc. (AMMJ) SoHum Living Soil Earned 2017 High Times STASH Award For Best Potting Mix

American Cannabis Company, Inc. Announces SoHum Living Soil Earned 2017 High Times…

Green Thumb Industries Inc. (GTBIF) Expands Retail Footprint in Massachusetts Through Acquisition of GreenStar Herbals, Inc.

Green Thumb Industries Expands Retail Footprint in Massachusetts Through Acquisition of GreenStar…

Maricann Group Inc. (MRRCF) Enters into Non-Binding Term Sheet for Strategic Joint Venture in Italy

Maricann Enters into Non-Binding Term Sheet for Strategic Joint Venture in Italy…